Non Alcoholic Steatohepatitis Recent News
Metacrine Posts Data From MET409 Combination Trial In Diabetes, NASH Patients
Galmed Reveals Early Aramchol Data From Late-Stage NASH Trial
Inventiva Plans To Start Lanifibranor Combo Study In NASH, Diabetes In 2022
Axcella To Test NASH Candidate In Long COVID Patients
Enanta To Discontinue Internal Development Of NASH Candidates
Fast Track Status Expanded For Inventiva's NASH Treatment
Hepion Pharma Shares Encouraging Biomarker Data From NASH Trial
Why Are Hepion Pharma Shares Moving Higher Premarket Monday?
Lipocine Meets Resolution Regulatory Endpoint In Mid-Stage NASH Trial
Siemens' Fatty Liver Disease Blood Test Wins FDA De Novo Clearance
Corcept Stops Phase 2 NASH Study With Miricorilant Due To Elevated Liver Enzymes In Patients
89bio's NASH Candidate Shows Clinically Meaningful Outcomes At ENDO Conference
A Primer On NASH